PortfoliosLab logo
CABA vs. IOVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CABA and IOVA is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

CABA vs. IOVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cabaletta Bio, Inc. (CABA) and Iovance Biotherapeutics, Inc. (IOVA). The values are adjusted to include any dividend payments, if applicable.

-90.00%-80.00%-70.00%-60.00%-50.00%December2025FebruaryMarchAprilMay
-88.10%
-91.47%
CABA
IOVA

Key characteristics

Sharpe Ratio

CABA:

-0.82

IOVA:

-1.00

Sortino Ratio

CABA:

-2.12

IOVA:

-2.30

Omega Ratio

CABA:

0.76

IOVA:

0.69

Calmar Ratio

CABA:

-0.95

IOVA:

-0.88

Martin Ratio

CABA:

-1.31

IOVA:

-1.85

Ulcer Index

CABA:

69.29%

IOVA:

47.31%

Daily Std Dev

CABA:

109.65%

IOVA:

87.02%

Max Drawdown

CABA:

-96.63%

IOVA:

-99.37%

Current Drawdown

CABA:

-95.31%

IOVA:

-98.90%

Fundamentals

Market Cap

CABA:

$64.95M

IOVA:

$1.17B

EPS

CABA:

-$2.34

IOVA:

-$1.28

PS Ratio

CABA:

0.00

IOVA:

7.12

PB Ratio

CABA:

0.43

IOVA:

1.65

Total Revenue (TTM)

CABA:

$0.00

IOVA:

$163.35M

Gross Profit (TTM)

CABA:

-$426.00K

IOVA:

$41.24M

EBITDA (TTM)

CABA:

-$85.77M

IOVA:

-$255.01M

Returns By Period

In the year-to-date period, CABA achieves a -47.58% return, which is significantly higher than IOVA's -76.35% return.


CABA

YTD

-47.58%

1M

5.31%

6M

-73.50%

1Y

-90.26%

5Y*

-31.15%

10Y*

N/A

IOVA

YTD

-76.35%

1M

-46.48%

6M

-83.47%

1Y

-86.99%

5Y*

-45.49%

10Y*

-16.20%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CABA vs. IOVA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CABA
The Risk-Adjusted Performance Rank of CABA is 66
Overall Rank
The Sharpe Ratio Rank of CABA is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of CABA is 22
Sortino Ratio Rank
The Omega Ratio Rank of CABA is 44
Omega Ratio Rank
The Calmar Ratio Rank of CABA is 22
Calmar Ratio Rank
The Martin Ratio Rank of CABA is 1414
Martin Ratio Rank

IOVA
The Risk-Adjusted Performance Rank of IOVA is 22
Overall Rank
The Sharpe Ratio Rank of IOVA is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of IOVA is 11
Sortino Ratio Rank
The Omega Ratio Rank of IOVA is 22
Omega Ratio Rank
The Calmar Ratio Rank of IOVA is 33
Calmar Ratio Rank
The Martin Ratio Rank of IOVA is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CABA vs. IOVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cabaletta Bio, Inc. (CABA) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current CABA Sharpe Ratio is -0.82, which is comparable to the IOVA Sharpe Ratio of -1.00. The chart below compares the historical Sharpe Ratios of CABA and IOVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00December2025FebruaryMarchAprilMay
-0.82
-1.00
CABA
IOVA

Dividends

CABA vs. IOVA - Dividend Comparison

Neither CABA nor IOVA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CABA vs. IOVA - Drawdown Comparison

The maximum CABA drawdown since its inception was -96.63%, roughly equal to the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for CABA and IOVA. For additional features, visit the drawdowns tool.


-95.00%-90.00%-85.00%-80.00%December2025FebruaryMarchAprilMay
-95.31%
-96.67%
CABA
IOVA

Volatility

CABA vs. IOVA - Volatility Comparison

The current volatility for Cabaletta Bio, Inc. (CABA) is 26.07%, while Iovance Biotherapeutics, Inc. (IOVA) has a volatility of 63.30%. This indicates that CABA experiences smaller price fluctuations and is considered to be less risky than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%December2025FebruaryMarchAprilMay
26.07%
63.30%
CABA
IOVA

Financials

CABA vs. IOVA - Financials Comparison

This section allows you to compare key financial metrics between Cabaletta Bio, Inc. and Iovance Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0
73.69M
(CABA) Total Revenue
(IOVA) Total Revenue
Values in USD except per share items